Related Experiment Videos

Separation of synthetic phosphorothioate oligonucleotides from phosphodiester-defect species by strong-anion exchange

B J Bergot¹, G Zon

¹Applied Biosystems, Inc., Therapeutics Group, Foster City, California 94404.

Annals of the New York Academy of Sciences

|October 28, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pheromone biosynthetic pathways: Conversion of ipsdienone to (-)-ipsdienol, a mechanism for enantioselective reduction in the male bark beetle,Ips paraconfusus.

Journal of chemical ecology·2013

Preclinical and clinical experience of antisense therapy for solid tumors.

Current opinion in molecular therapeutics·2001

Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA).

Antisense & nucleic acid drug development·2001

Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide.

Antisense & nucleic acid drug development·1999

Comparison of binding of N3'-->P5' phosphoramidate and phosphorothioate oligonucleotides to cell surface proteins of cultured cells.

Antisense & nucleic acid drug development·1999

c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.

Cancer research·1998

See all related articles